Asahi Intecc Co ( (AHICF) ) has released its Q1 earnings. Here is a breakdown of the information Asahi Intecc Co presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Asahi Intecc Co., Ltd. is a Japanese company listed on the Tokyo and Nagoya Stock Exchanges, specializing in the medical device sector, particularly known for its innovative medical and industrial components.
In its latest earnings report for the three months ended September 30, 2025, Asahi Intecc Co. reported strong financial performance with significant year-on-year growth in net sales and profits. The company saw a 15.6% increase in net sales, reaching 36,058 million yen, and a 34.0% rise in operating profit, amounting to 13,035 million yen.
Key financial highlights include a 47.0% increase in ordinary profit to 12,887 million yen and a 35.7% rise in profit attributable to owners of the parent, totaling 9,205 million yen. The Medical Division experienced a 12.3% increase in net sales, driven by strong performance in both cardiovascular and non-cardiovascular fields, while the Device Division saw a 47.4% increase in net sales, bolstered by the inclusion of Nitta Mold as a subsidiary.
Looking ahead, Asahi Intecc Co. remains optimistic about its growth trajectory, with expectations of continued strong performance in its core divisions and positive impacts from foreign exchange trends. However, the company acknowledges potential fluctuations in sales trends and is reviewing its full-year forecast to account for these uncertainties.